ANAPTYSBIO, INC. (ANAB) Debt Components
- 2020-12-31: Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, NoncurrentUSD (m).
- 2020-09-30: Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, NoncurrentUSD (m).
- 2020-06-30: Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, NoncurrentUSD (m).
- 2020-03-31: Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, NoncurrentUSD (m).
ANAPTYSBIO, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable to Bank, Noncurrent USD |
|---|---|---|
| 2020-12-31 | $0.00 | (m) |
| 2020-09-30 | $0.00 | (m) |
| 2020-06-30 | $0.00 | (m) |
| 2020-03-31 | $0.00 | (m) |
| 2019-12-31 | $1.38M | (m) |
| 2019-09-30 | $3.08M | (m) |
| 2019-06-30 | $4.78M | (m) |
| 2019-03-31 | $6.49M | (m) |
| 2018-12-31 | $7.57M | (m) |
| 2018-12-31 | (m) | $625.00K |
| 2018-09-30 | $7.50M | $2.41M |
| 2018-06-30 | $7.50M | $4.12M |
| 2018-03-31 | $7.50M | $5.83M |
| 2017-12-31 | $6.88M | $7.55M |
| 2017-09-30 | $5.00M | $9.27M |
| 2017-06-30 | $3.12M | $10.99M |
| 2017-03-31 | $1.25M | $12.71M |
| 2016-12-31 | $0.00 | $13.81M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |